Perillyl alcohol for glioblastoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 10 Mar 2016: Trial registered, NCT02704858
  2. 1 Aug 2017: Trial started, NCT02704858

The trials

NCT02704858: Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma

State
Under way
Phase
Phase 1 and Phase 2
People
49 planned
Started
1 Aug 2017
Primary completion
30 Nov 2026
Arms
NEO100 Phase 1, NEO100 Phase 2A
Results
None posted
  1. 10 Mar 2016: Trial registered
  2. 1 Aug 2017: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.